8-K

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

_________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report (Date of earliest event reported): June 16, 2006

OPHTHALMIC IMAGING SYSTEMS
(Exact Name of Registrant as Specified in its Charter)

CALIFORNIA	1-11140	94-3035367
(State or Other Jurisdiction of	(Commission File Number)	(I.R.S. Employer Identification No.)
Incorporation)

221 Lathrop Way, Suite I Sacramento, California	95815
(Address of Principal Executive)	(Zip Code)

(Registrant's telephone number, including area code): (916) 646-2020

                                                           Not Applicable                                                            
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01.       Regulation FD Disclosure.

              On June 16, 2006, Ophthalmic Imaging Systems (the “Registrant”) issued a press release announcing that it will be presenting at the Wall Street Reporter’s 8^th annual Small-Cap Discovery Conference, an investment event for micro-cap companies, on Wednesday, June 21, 2006.  A copy of the Registrant’s press release is attached hereto as Exhibit 99.1.

Item 9.01.       Financial Statements and Exhibits.

              (c) Exhibits

Exhibit Number	Description
99.1	Press Release of the Registrant dated June 16, 2006.

SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 19, 2006	OPHTHALMIC IMAGING SYSTEMS
	By: /s/ Ariel Shenhar
	Name: Ariel Shenhar        Title: Chief Financial Officer

EX-99

OPHTHALMIC IMAGING SYSTEMS

221 Lathrop Way, Suite I
SACRAMENTO, CA 95815
CONTACTS:
Gil Allon, CEO
Ariel Shenhar, CFO
(916) 646-2020
INVESTOR RELATIONS
TODD FROMER / GARTH RUSSELL
KCSA Worldwide
212-896-1215 / 212-896-1250

FOR IMMEDIATE RELEASE

Ophthalmic Imaging Systems to Present at the
Wall Street Reporter Conference on June 21st

SACRAMENTO, Calif., June 16, 2006 — Ophthalmic Imaging Systems (OTCBB:OISI), a leading provider of ophthalmic digital imaging systems, announced today that it will be presenting at the Wall Street Reporter’s 8^th annual Small-Cap Discovery Conference, an investment event for micro-cap companies, on Wednesday, June 21, 2006. 

During the event, Steven Verdooner, President of OIS, will discuss the Company’s past performance, and strategy for growth. 

The conference will be held in New York City at the Roosevelt Hotel, located at 45 east 45th St. For a complete schedule, or to register to attend the conference, please visit www.wallstreetreporter.com.

ABOUT OPHTHALMIC IMAGING SYSTEMS

Ophthalmic Imaging Systems (www.oisi.com), a majority-owned subsidiary of MediVision, is the leading provider of ophthalmic digital imaging systems. The Company designs, develops, manufactures and markets digital imaging systems and informatics solutions for the eye care market. With over twenty years in the ophthalmic imaging business, the Company has consistently introduced new, innovative technology. The Company, together with MediVision, co-market and support their products through an extensive network of dealers, distributors, and direct representatives.

Statements in this press release which are not historical data are forward-looking statements which involve known and unknown risks, uncertainties, or other factors not under the Company’s control, which may cause actual results, performance, or achievements of the Company to be materially different from the results, performance, or other expectations implied by these forward-looking statements. These factors include, but are not limited to, those detailed in the Company’s periodic filings with the Securities and Exchange Commission.

###